Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p6
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 6/30)
Character Range: 19459–22304

"Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[30] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 70 mg [Brand: Dasatinib Sandoz; Maximum Quantity: 60; Number of
Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[31] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 70 mg [Brand: Dasatinib SUN; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[32] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 70 mg [Brand: DASATINIB-TEVA; Maximum Quantity: 60; Number of
Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[33] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 70 mg [Brand: Dasatinib Viatris; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[34] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 70 mg [Brand: Sprycel; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[35] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 100 mg [Brand: Dasatinib ARX; Maximum Quantity: 30; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[36] Schedule 1, Part 1,